Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$224.58 - $256.19 $101,959 - $116,310
-454 Reduced 10.85%
3,732 $932 Million
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $177,696 - $223,804
960 Added 29.76%
4,186 $968 Million
Q3 2023

Nov 02, 2023

BUY
$233.08 - $265.59 $280,628 - $319,770
1,204 Added 59.55%
3,226 $800 Million
Q2 2023

Aug 03, 2023

SELL
$224.99 - $256.14 $57,147 - $65,059
-254 Reduced 11.16%
2,022 $485 Million
Q1 2023

May 05, 2023

SELL
$239.75 - $277.0 $28,770 - $33,240
-120 Reduced 5.01%
2,276 $574 Million
Q4 2022

Feb 17, 2023

BUY
$241.42 - $282.29 $10,622 - $12,420
44 Added 1.87%
2,396 $636 Million
Q3 2022

Nov 04, 2022

SELL
$247.06 - $1507.4 $1,729 - $10,551
-7 Reduced 0.3%
2,352 $607 Million
Q2 2022

Aug 05, 2022

BUY
$237.11 - $299.66 $34,855 - $44,050
147 Added 6.65%
2,359 $598,000
Q1 2022

May 04, 2022

BUY
$257.27 - $315.76 $11,062 - $13,577
43 Added 1.98%
2,212 $649,000
Q4 2021

Feb 04, 2022

BUY
$292.08 - $329.01 $265,500 - $299,070
909 Added 72.14%
2,169 $714,000
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $10,343 - $12,632
-38 Reduced 2.93%
1,260 $384,000
Q2 2021

Aug 11, 2021

BUY
$225.08 - $271.69 $38,938 - $47,002
173 Added 15.38%
1,298 $348,000
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $50,971 - $59,016
-240 Reduced 17.58%
1,125 $253,000
Q4 2020

Feb 10, 2021

SELL
$212.5 - $245.46 $151,512 - $175,012
-713 Reduced 34.31%
1,365 $303,000
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $184,941 - $254,104
-1,437 Reduced 40.88%
2,078 $367,000
Q1 2020

Apr 30, 2020

SELL
$121.39 - $169.05 $80,117 - $111,573
-660 Reduced 15.81%
3,515 $487,000
Q4 2019

Jan 31, 2020

BUY
$133.47 - $153.48 $102,905 - $118,333
771 Added 22.65%
4,175 $641,000
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $8,124 - $8,788
60 Added 1.79%
3,404 $492,000
Q2 2019

Aug 07, 2019

BUY
$124.88 - $143.73 $124,505 - $143,298
997 Added 42.48%
3,344 $478,000
Q1 2019

May 01, 2019

BUY
$97.62 - $132.29 $229,114 - $310,484
2,347 New
2,347 $310,000
Q4 2018

Jan 31, 2019

SELL
$94.85 - $109.54 $248,506 - $286,994
-2,620 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$98.13 - $108.9 $12,756 - $14,157
130 Added 5.22%
2,620 $285,000
Q2 2018

Aug 09, 2018

SELL
$96.1 - $103.24 $2.1 Million - $2.26 Million
-21,870 Reduced 89.78%
2,490 $246,000
Q1 2018

May 09, 2018

SELL
$92.16 - $103.8 $82,022 - $92,382
-890 Reduced 3.52%
24,360 $2.39 Million
Q4 2017

Feb 09, 2018

BUY
$85.26 - $94.62 $42,630 - $47,310
500 Added 2.02%
25,250 $2.34 Million
Q3 2017

Nov 07, 2017

SELL
$79.29 - $88.45 $313,195 - $349,377
-3,950 Reduced 13.76%
24,750 $2.12 Million
Q2 2017

Aug 09, 2017

BUY
N/A
28,700
28,700 $2.42 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bank Pictet & Cie (Asia) LTD Portfolio

Follow Bank Pictet & Cie (Asia) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.